Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health Corporation reported strong financial results for Q4 and full-year 2021, with total revenues reaching $76.6 billion for Q4 and $292.1 billion for the year, marking increases of 10.1% and 8.7% respectively. GAAP diluted EPS was $0.98 in Q4 and $5.95 for the year. Adjusted EPS rose to $1.98 for Q4 and $8.40 for the full year. The company also confirmed guidance for 2022, projecting GAAP EPS between $7.04 and $7.24.
CVS continued its pandemic response, administering over 59 million COVID-19 vaccines. A 10% increase in the annual dividend and a $10 billion share repurchase program were announced.
CVS Health has partnered with Medable to enhance patient access and engagement in clinical trials at select MinuteClinic locations. This collaboration aims to address low participation rates in clinical studies, particularly among underrepresented groups. Medable's software platform will facilitate decentralized clinical trial delivery and real-world evidence generation. CVS Health aims to leverage its extensive community reach to improve patient outcomes and support diversity in clinical research.
CVS Health has announced a significant investment of $12.7 million in partnership with R4 Capital to construct 204 affordable housing units in Nashville's Chestnut Hill neighborhood. This initiative aims to tackle racial inequity and health determinants by providing affordable housing for families earning 30% - 70% of the Area Median Income. The housing development, named 101 Factory, will feature various amenities and services aimed at enhancing residents' health and well-being. CVS Health has a broader commitment, having invested $185 million in affordable housing nationwide in 2021.
CVS Health has announced a $6.5 million investment to create Charity's House Place, a 36-unit supportive housing community in Denver aimed at aiding individuals experiencing homelessness and those with disabilities. This initiative reflects CVS's commitment to health equity, addressing social determinants of health in underserved areas. The project will collaborate with local organizations to provide essential services, ensuring residents can maintain stable housing and improve their health. In 2021, CVS invested $185 million in affordable housing, underscoring its ongoing dedication to community support.
CVS Health announced a collaboration with Uber Health to provide free transportation support for individuals needing access to medical care, work, or educational programs. This partnership is part of CVS's Health Zones initiative aimed at reducing health disparities in high-risk communities, beginning in cities like Atlanta, Columbus, and Hartford. The initiative focuses on social determinants of health, including transportation. CVS Health has invested $185 million in affordable housing and $1.3 billion over 20 years to improve health equity across America.
CVS Health (NYSE: CVS) announce a conference call on February 9, 2022, at 8:00 a.m. ET to discuss its fourth quarter and full year 2021 financial results. The call will be accessible via an audio webcast on the CVS Health Investor Relations website. CVS is a leading health solutions company, improving community health through 300,000 dedicated colleagues, including 40,000 physicians. The company emphasizes affordable health services and care management, aiming to enhance access and lower costs for consumers.
CVS Health announced that President and CEO Karen S. Lynch and CFO Shawn Guertin will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at approximately 8:15 am ET. This presentation underscores CVS's commitment to delivering comprehensive health solutions across America, with approximately 300,000 colleagues including over 40,000 healthcare professionals. The conference is a significant event in the healthcare sector, providing insights into CVS's strategic direction and initiatives.
CVS Health announced an investment of $11.6 million in affordable housing in Austin, Texas, aimed at providing 171 units of permanent supportive housing. This initiative aligns with CVS Health's commitment to address racial inequity and social determinants of health in underserved communities. The project, Espero Austin at Rutland, will support individuals experiencing homelessness, those with disabilities, and youth aging out of foster care. CVS collaborates with local organizations to enhance the well-being and health of residents through various support services.
CVS Health (NYSE: CVS) has declared a quarterly dividend of $0.55 per share on its Common Stock. This dividend is set to be paid on February 1, 2022, for shareholders on record as of January 21, 2022. With over 300,000 employees, including 40,000 healthcare professionals, CVS Health focuses on enhancing healthcare access and affordability. The company aims to improve community health outcomes while navigating the complexities of the healthcare system effectively.
CVS Health revealed its strategic growth plans during the 2021 Investor Day, focusing on enhancing healthcare accessibility and affordability. CEO Karen S. Lynch emphasized the importance of expanding consumer-centric services and enhancing primary care capabilities. Key initiatives include closing approximately 900 stores, launching new health products, and driving a digital-first approach. For 2021, CVS expects revenues of at least $290.3 billion and has initiated 2022 guidance of $304.0 to $309.0 billion. The company will also increase its dividend by 10% and has authorized a $10 billion share repurchase program.